Menu

Duke Sued for Millions over Fraudulent Data

A lawsuit claims that Duke University and biologist Erin Potts-Kant used bad data in projects funded by dozens of government grants.

Sep 6, 2016
Jef Akst

FLICKR, PENSDEVILSixty grants worth some $200 million—that’s what biologist Joseph Thomas claims is affected by fraudulent data from Duke University and biologist Erin Potts-Kant, Thomas’s former supervisor, ScienceInsider and Retraction Watch reported last week (September 1). And the university may have to shell out three times that amount if Thomas’s lawsuit is successful.

The Duke case “should scare all [academic] institutions around the country,” attorney Joel Androphy of Berg & Androphy told Retraction Watch. If successful, he added, it could “open the floodgates” to other whistleblowing cases on research misconduct in academia.

Potts-Kant was arrested on charges of embezzlement (totaling more than $25,000) in March 2013. She pled guilty, received a fine and probation, and was ordered to perform community service. Following a Duke investigation, 15 of Potts-Kant’s papers were retracted, some citing “unreliable” data. Additional publications have corrections or expressions of concern.

The lawsuit filed by Thomas was unsealed by a US district court last month, according to the news report; in it, Thomas claims that other researchers at Duke were aware of the problems with Pott-Kant’s work but that the university withheld information from federal funding agencies.

According to Thomas’s complaint, the misconduct affects at least 49 grants worth $82.8 million from federal agencies such as the National Institutes of Health (NIH) and the Environmental Protection Agency, and that an additional 15 NIH grants, worth $120.9 million, were awarded based on fraudulent data.

Duke responded to the accusations in a statement: “Even though the full scope of Ms. Potts-Kant’s actions were not known at the time, Duke notified several government agencies in June 2013 about the matter and immediately launched a formal scientific misconduct investigation, as required by federal law.”

January 2019

Cannabis on Board

Research suggests ill effects of cannabinoids in the womb

Marketplace

Sponsored Product Updates

WIN a VIAFLO 96/384 to supercharge your microplate pipetting!
WIN a VIAFLO 96/384 to supercharge your microplate pipetting!
INTEGRA Biosciences is offering labs the chance to win a VIAFLO 96/384 pipette. Designed to simplify plate replication, plate reformatting or reservoir-to-plate transfers, the VIAFLO 96/384 allows labs without the space or budget for an expensive pipetting robot to increase the speed and throughput of routine tasks.
FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX has announced that their digital PCR assets, including the CONSTELLATION® series of instruments, is being acquired by QIAGEN N.V. (NYSE: QGEN, Frankfurt Stock Exchange: QIA) for up to $260 million ($125 million upfront payment and $135 million of milestones).  QIAGEN has announced plans for a global launch in 2020 of a new series of digital PCR platforms that utilize the advanced dPCR technology developed by FORMULATRIX combined with QIAGEN’s expertise in assay development and automation.
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
With this application note from Taconic, learn about the power that the CRISPR/Cas system has to revolutionize the field of custom mouse model generation!
Translational Models of Obesity, Dysmetabolism, Diabetes, and Complications
Translational Models of Obesity, Dysmetabolism, Diabetes, and Complications
This webinar, from Crown Bioscience, presents a unique continuum of translational dysmetabolic platforms that more closely mimic human disease. Learn about using next-generation rodent and spontaneously diabetic non-human primate models to accurately model human-relevant disease progression and complications related to obesity and diabetes here!